Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:93 (8 January), doi:10.1136/bmj.330.7482.93-a
| The first 150 words of the full text of this article appear below. |
EDITORMuir Gray says that evidence based policy making is about taking decisions based on evidence and the needs and values of the population.1 Surely one of the major barriers to better evidence based policy is that the evidence base is weak and too late.
In clinical practice, evidence in randomised controlled trials often uses selected groups of patients, excluding those with inconvenient comorbidities who would spoil the trial design. Yet these are the very patients who would benefit from the evidence base. Therefore, when a general practitioner tries to explain the risks and benefits of the options for managing atrial fibrillation to a patient with depression, the decision has to be made on some trial, some knowledge of pharmocokinetics, and lots of guesswork.
So it is with policy. How can we tell whether a policy will or will not work in a different time frame, environment, or context
Tim Wilson, general practitioner
Mill Stream Surgery, Benson, Oxfordshire OX10 6RL Tim.wilson@gp-k84036.nhs.uk